Alterity Therapeutics (ATHE) Return on Assets (2009 - 2025)

Alterity Therapeutics' Return on Assets history runs 13 years deep, the most recent figure standing at 0.0% for Q4 2025.

• On a quarterly basis, Return on Assets rose 2.0% year-over-year to 0.0% in Q4 2025; TTM through Dec 2025 was 0.0%, a 2.0% increase from a year earlier, with the FY2023 full-year figure at 0.0%, changed 0.0% from the prior year.
• Return on Assets improved to 0.0% in Q4 2025 per ATHE's latest filing, from 0.01% in the prior quarter.
• Across five years, Return on Assets topped out at 0.0% in Q2 2021 and bottomed at 0.03% in Q4 2023.
• The 5-year median for Return on Assets is 0.01% (2025), against an average of 0.01%.
• Across the five-year window, Return on Assets climbed 2 bps in 2021 and decreased 2 bps in 2023, its largest moves.
• Year by year, Return on Assets stood at 0.0% in 2021, then tumbled by 150 bps to 0.0% in 2022, then plunged by 601 bps to 0.03% in 2023, then gained by 11 bps to 0.02% in 2024, then surged by 83 bps to 0.0% in 2025.
• Per Business Quant, the three latest ATHE Return on Assets figures stand at 0.0% (Q4 2025), 0.01% (Q2 2025), and 0.02% (Q4 2024).